Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11453583 | 0.85 | HTT (0.41) | HTTMAPTCYP3A4TSHRMEN1 | |
| SCHEMBL8970777 | 0.83 | MAPT (0.43) | HTTMAPTCYP3A4TSHRMEN1 | |
| SCHEMBL4371618 | 0.82 | SLC9A1 (0.36) | CYP3A4ALDH1A1ATMPOLBSMN1; SMN2 | |
| SCHEMBL5984477 | 0.82 | HTT (0.40) | HTTMAPTCYP3A4TSHRMEN1 | |
| SCHEMBL18601440 | 0.79 | MAOB (0.40) | CYP3A4ALDH1A1ATMPOLBALOX15 | |
| SCHEMBL5320069 | 0.78 | LMNA (0.37) | HTTMAPTTSHRKMT2AALDH1A1 | |
| SCHEMBL4234394 | 0.75 | POLB (0.37) | MAPTCYP3A4TSHRMEN1KMT2A | |
| SCHEMBL8501573 | 0.74 | NR4A2 (0.37) | TSHRALDH1A1KDM4EPOLBSMN1; SMN2 | |
| SCHEMBL6903843 | 0.73 | POLB (0.36) | MAPTCYP3A4TSHRALDH1A1ATM | |
| SCHEMBL9545947 | 0.73 | POLB (0.36) | MAPTTSHRMEN1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190161429-A1 | Aromatic Esters and Polyesters, Production Without Esterification Catalyst, and Use | EXXONMOBIL CHEMICAL PATENTS INC. | 2019-05-30 | — | — | US | disclosed |
| EP-3475255-A1 | AROMATIC ESTERS AND POLYESTERS, PRODUCTION WITHOUT ESTERIFICATION CATALYST, AND USE | ExxonMobil Chemical Patents Inc. (US) | 2019-05-01 | — | — | EP | disclosed |
| WO-2017222692-A1 | AROMATIC ESTERS AND POLYESTERS, PRODUCTION WITHOUT ESTERIFICATION CATALYST, AND USE | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2017-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190161429-A1 | Aromatic Esters and Polyesters, Production Without Esterification Catalyst, and Use | PAH, ALKBH3, ALK | HTT 1816/4885MAPT 313/4885CYP3A4 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.